Therefore, like maprotiline treatment, blocking HRH1 significantly protects RGCs and ONs and preserves visual functions in two mouse optic neuropathy models, indicating the promising therapeutic potential of HRH1 inhibition in traumatic and glaucomatous neurodegeneration. The gene discussed is HRH1; the disease is Optic neuropathy.